GlassScriptPhysician profile
Christopher A Vaughan
NPI 1548441967
$1,812.77
in general payments reported to CMS, 2019-2025
12 companies · $177 in 2025
The $177 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $204 · 2022: $1,251 · 2023: $118 · 2024: $61.99 · 2025: $177.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $358.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $357.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pylant Medical | $1,230.12 | 2022 | |
| Smith+Nephew, INC. | $130.93 | 2021 | |
| Ethicon US, LLC | $96.40 | 2025 | Vistaseal, Ethicon, Dermabond |
| Bioventus LLC | $78.23 | 2023 | Exogen Ultrasound Bone Healing System, Durolane |
| Baudax Bio INC. | $73.54 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $48.68 | 2025 | |
| Depuy Synthes Sales INC. | $46.01 | 2024 | Na, Multiloc |
| Ferring Pharmaceuticals INC. | $36.13 | 2022-2023 | Euflexxa |
| Innovation Technologies INC | $24.75 | 2023 | Irrisept |
| Molnlycke Health Care US, LLC | $17.92 | 2025 | Biogel Pi Orthopro, Biogel Pi Micro Indicator Underglove, Biogel Pi Indicator Underglove |
| Integra Lifesciences Corporation | $15.98 | 2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Pacira Pharmaceuticals Incorporated | $14.08 | 2025 | Zilretta, Iovera |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Vaughan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.